New combo therapy shows promise for hard-to-treat liver cancer
Disease control
Ongoing
This study looks at how well a combination of two drugs (atezolizumab and bevacizumab) plus local treatments like chemo injections or radiation works for people with advanced liver cancer that can't be removed by surgery. Researchers will track over 1,100 patients to see how long…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated May 17, 2026 04:13 UTC